7Baggers
 Outlook To Resubmit Ophthalmic Bevacizumab To The FDA By Year End  insights.citeline.com Thu, 02 Oct 2025 11:30:48 GMT
 OTLK Receives Neutral Rating from HC Wainwright & Co. | OTLK Sto  GuruFocus Tue, 30 Sep 2025 12:44:14 GMT
 H.C. Wainwright maintains Neutral rating on Outlook Therapeutics stock  Investing.com Tue, 30 Sep 2025 11:47:00 GMT
 Outlook Therapeutics Completes FDA Meeting on ONS-5010  TipRanks Mon, 29 Sep 2025 21:36:32 GMT
 Outlook Therapeutics Stock: To Buy or Not?  StocksToTrade Mon, 29 Sep 2025 18:04:00 GMT
 Outlook Therapeutics stock surges after productive FDA meeting  Investing.com Mon, 29 Sep 2025 15:52:00 GMT
 Outlook Therapeutics (OTLK) Engages in Constructive Talks with F  GuruFocus Mon, 29 Sep 2025 14:15:42 GMT
 Outlook Therapeutics (OTLK) Aims for BLA Resubmission by Year-En  GuruFocus Mon, 29 Sep 2025 13:33:38 GMT
 Outlook Therapeutics plans FDA BLA resubmission for wet AMD treatment  Investing.com India Mon, 29 Sep 2025 13:24:45 GMT
 Outlook Therapeutics Provides Update on Type A Meeting with FDA  GlobeNewswire Mon, 29 Sep 2025 12:48:39 GMT
 otlk: ascendiant capital lowers price target while maintaining b  GuruFocus Mon, 22 Sep 2025 10:04:52 GMT
 published on: 2025-09-19 03:10:54  خودرو بانک Thu, 18 Sep 2025 23:41:51 GMT
 largest borrow rate increases among liquid names  TipRanks Wed, 17 Sep 2025 13:47:25 GMT
 published on: 2025-09-16 00:11:18  خودرو بانک Mon, 15 Sep 2025 20:43:46 GMT
 outlook therapeutics announces ceo appointment  MSN Wed, 10 Sep 2025 08:12:32 GMT
 Outlook Therapeutics announces CEO appointment  MSN Tue, 09 Sep 2025 23:29:46 GMT
 outlook therapeutics cco jeff evanson steps down  The Globe and Mail Sat, 06 Sep 2025 21:34:00 GMT
 outlook therapeutics cco jeff evanson steps down  TipRanks Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 23:49:13  Newser Wed, 03 Sep 2025 04:49:13 GMT
 us fda emphasizes primary endpoint primacy in vatiquinone, lytenava crls  insights.citeline.com Wed, 03 Sep 2025 00:46:38 GMT
 outlook therapeutics submits type a meeting request to fda  TipRanks Tue, 02 Sep 2025 13:08:05 GMT
 Outlook Therapeutics receives second FDA CRL over wet AMD BLA  Eyes On Eyecare Tue, 02 Sep 2025 07:00:00 GMT
 Outlook Therapeutics Requests Type A Meeting with FDA  Yahoo Finance Tue, 02 Sep 2025 07:00:00 GMT
 FDA Issues Complete Response Letter to Outlook Therapeutics  TipRanks Tue, 02 Sep 2025 07:00:00 GMT
 vktx stock forecast: 2025-2040 viking therapeutics future outlook  Exla Resources Tue, 02 Sep 2025 03:56:00 GMT
 published on: 2025-09-01 20:45:57  Newser Tue, 02 Sep 2025 01:45:57 GMT
 outlook therapeutics reports q3 revenue  AOL.com Mon, 01 Sep 2025 03:06:11 GMT
 published on: 2025-08-30 17:42:46  Newser Sat, 30 Aug 2025 22:42:46 GMT
 published on: 2025-08-30 12:09:11  Newser Sat, 30 Aug 2025 17:09:11 GMT
 here's why viking therapeutics bounced back today  AOL.com Sat, 30 Aug 2025 13:10:41 GMT
 here's why shares in viking therapeutics crashed this week  AOL.com Sat, 30 Aug 2025 01:24:39 GMT
 top midday decliners  富途牛牛 Fri, 29 Aug 2025 20:34:46 GMT
 published on: 2025-08-29 02:42:31  Newser Fri, 29 Aug 2025 07:42:31 GMT
 fda dampens outlook with another ophthalmic bevacizumab crl  insights.citeline.com Fri, 29 Aug 2025 07:00:00 GMT
 outlook bleaker after latest lytenava blow  The Pharma Letter Fri, 29 Aug 2025 07:00:00 GMT
 otlk stock crashes 54% as fda issues second crl for eye disease drug  Yahoo Finance Fri, 29 Aug 2025 07:00:00 GMT
 outlook therapeutics downgraded at h.c. wainwright  TipRanks Fri, 29 Aug 2025 07:00:00 GMT
 outlook therapeutics receives crl for bla resubmission of lytenava  Pharmaceutical Executive Fri, 29 Aug 2025 07:00:00 GMT
 outlook therapeutics shares fall after hc wainwright downgrade  MarketScreener Fri, 29 Aug 2025 07:00:00 GMT
 sector update: health care stocks softer late afternoon  MarketScreener Thu, 28 Aug 2025 19:41:11 GMT
 sector update: health care  MarketScreener Thu, 28 Aug 2025 19:22:11 GMT
 fda requests confirmatory evidence on wet amd therapy  Conexiant Thu, 28 Aug 2025 17:35:23 GMT
 guggenheim downgrades outlook therapeutics(otlk.us) to hold rating  富途牛牛 Thu, 28 Aug 2025 17:31:00 GMT
 transcript : outlook therapeutics, inc. - special call  MarketScreener Thu, 28 Aug 2025 14:35:34 GMT
 otlk stock crashes 54% as fda issues second crl for eye disease drug  Barchart.com Thu, 28 Aug 2025 13:23:00 GMT

Outlook Therapeutics, Inc
(NASDAQ:OTLK) 

OTLK stock logo

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Ph...

Founded: 2009
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends